GSE143790 BCL9 knockdown 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE143790_BCL9 knockdown_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE143790_BCL9 knockdown_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE143790_BCL9 knockdown_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE143790_BCL9 knockdown_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

MIR4435-2 host gene

Gene

SRC kinase signaling inhibitor 1

Gene

Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene

Gene

brain cytoplasmic RNA 1

Gene

FMC1-LUC7L2 readthrough

Gene

long intergenic non-protein coding RNA 294

Gene

family with sequence similarity 225 member A

Gene

MIR3667 host gene

Gene

TMX2-CTNND1 readthrough (NMD candidate)

Gene

long intergenic non-protein coding RNA 2188


  • Gene

    SRC kinase signaling inhibitor 1


  • Gene

    Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene


  • Gene

    brain cytoplasmic RNA 1


  • Gene

    FMC1-LUC7L2 readthrough


  • Gene

    long intergenic non-protein coding RNA 294


  • Gene

    family with sequence similarity 225 member A



  • Gene

    TMX2-CTNND1 readthrough (NMD candidate)


  • Gene

    long intergenic non-protein coding RNA 2188

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.